These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 20421820

  • 21. Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.
    Miller AA, Wang XF, Bogart JA, Hodgson LD, Rocha Lima CM, Radford JE, Vokes EE, Green MR, Cancer and Leukemia Group B (CALGB).
    J Thorac Oncol; 2007 Jul; 2(7):645-51. PubMed ID: 17607121
    [Abstract] [Full Text] [Related]

  • 22. Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancer.
    Stinchcombe TE, Lee CB, Moore DT, Rivera MP, Halle J, Limentani S, Rosenman JG, Socinski MA.
    J Thorac Oncol; 2008 Nov; 3(11):1279-85. PubMed ID: 18978563
    [Abstract] [Full Text] [Related]

  • 23. Dose-dense vinorelbine and docetaxel with Filgrastim support in patients with advanced nonsmall cell lung carcinoma.
    Page RD, Smith FP, Geils GF, Beall CL, Fridman M, Allen BJ.
    Cancer; 2005 Nov 01; 104(9):1956-61. PubMed ID: 16177986
    [Abstract] [Full Text] [Related]

  • 24. Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer.
    Iwasaki Y, Ohsugi S, Natsuhara A, Tsubokura T, Harada H, Ueda M, Arimoto T, Hara H, Yamada T, Takesako T, Kohno K, Hosogi S, Nakanishi M, Marunaka Y, Nishimura T.
    Cancer Chemother Pharmacol; 2006 Dec 01; 58(6):735-41. PubMed ID: 16565832
    [Abstract] [Full Text] [Related]

  • 25. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504.
    Gandara DR, Chansky K, Albain KS, Leigh BR, Gaspar LE, Lara PN, Burris H, Gumerlock P, Kuebler JP, Bearden JD, Crowley J, Livingston R, Southwest Oncology Group.
    J Clin Oncol; 2003 May 15; 21(10):2004-10. PubMed ID: 12743155
    [Abstract] [Full Text] [Related]

  • 26. Phase I study of concurrent high-dose three-dimensional conformal radiotherapy with chemotherapy using cisplatin and vinorelbine for unresectable stage III non-small-cell lung cancer.
    Sekine I, Sumi M, Ito Y, Horinouchi H, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Kubota K, Tamura T.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):953-9. PubMed ID: 21377282
    [Abstract] [Full Text] [Related]

  • 27. Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China.
    Su S, Li T, Lu B, Wang X, Li J, Chen M, Lu Y, Bai Y, Hu Y, Ouyang W, Ma Z, Li Q, Li H, Wang Y.
    Int J Radiat Oncol Biol Phys; 2015 Nov 15; 93(4):769-77. PubMed ID: 26530745
    [Abstract] [Full Text] [Related]

  • 28. Concurrent chemotherapy and short course radiotherapy in patients with stage IIIA to IIIB non-small cell lung cancer not eligible for radical treatment: results of a randomized phase II study.
    Nawrocki S, Krzakowski M, Wasilewska-Tesluk E, Kowalski D, Rucinska M, Dziadziuszko R, Sowa A.
    J Thorac Oncol; 2010 Aug 15; 5(8):1255-62. PubMed ID: 20592630
    [Abstract] [Full Text] [Related]

  • 29. Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer.
    Cardenal F, Arnaiz MD, Morán T, Jové J, Nadal E, Porta R, Solé JM, Brao I, Palmero R, Fuentes R, Núñez I, Caveda E, Cassinello A.
    Lung Cancer; 2011 Oct 15; 74(1):69-74. PubMed ID: 21353323
    [Abstract] [Full Text] [Related]

  • 30. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
    Giorgio CG, Pappalardo A, Russo A, Santini D, Di Rosa C, Di Salvo C, Castorina S, Marletta F, Bellissima G, Palermo N, Scuderi C, Bordonaro R.
    Anticancer Drugs; 2007 Jul 15; 18(6):713-9. PubMed ID: 17762402
    [Abstract] [Full Text] [Related]

  • 31. Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
    Harada H, Nishio M, Murakami H, Ohyanagi F, Kozuka T, Ishikura S, Naito T, Kaira K, Takahashi T, Horiike A, Nishimura T, Yamamoto N.
    Clin Lung Cancer; 2013 Jul 15; 14(4):440-5. PubMed ID: 23540866
    [Abstract] [Full Text] [Related]

  • 32. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ, Radiation Therapy Oncology Group.
    J Clin Oncol; 2005 May 20; 23(15):3480-7. PubMed ID: 15908657
    [Abstract] [Full Text] [Related]

  • 33. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
    Langer CJ, Curran WJ, Keller SM, Catalano RB, Litwin S, Blankstein KB, Haas N, Campli SN, Comis RL.
    Cancer J Sci Am; 1996 May 20; 2(2):99-105. PubMed ID: 9166507
    [Abstract] [Full Text] [Related]

  • 34. Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial.
    Pöttgen C, Eberhardt WE, Gauler T, Krbek T, Berkovic K, Jawad JA, Korfee S, Teschler H, Stamatis G, Stuschke M.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):809-15. PubMed ID: 19427744
    [Abstract] [Full Text] [Related]

  • 35. Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancer.
    Mornex F, Peignaux K, Germain T, Wautot V, Chouaki N, Bourayou N, Tourani JM.
    Lung Cancer; 2013 Apr 01; 80(1):68-74. PubMed ID: 23332163
    [Abstract] [Full Text] [Related]

  • 36. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ, Movsas B, Byhardt RW, Radiation Therapy Oncology Group 9609.
    J Clin Oncol; 2005 Aug 01; 23(22):4991-8. PubMed ID: 15939930
    [Abstract] [Full Text] [Related]

  • 37. Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer.
    Nakamura M, Koizumi T, Hayasaka M, Yasuo M, Tsushima K, Kubo K, Gomi K, Shikama N.
    Cancer Chemother Pharmacol; 2009 May 01; 63(6):1091-6. PubMed ID: 18818921
    [Abstract] [Full Text] [Related]

  • 38. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
    Langer CJ, Duffy K, Horwitz EM, Litwin S, Rosvold E, Schol J, Keenan E, Nicolaou N, Friedman CD, Ridge JA.
    Cancer Invest; 2006 Mar 01; 24(2):164-73. PubMed ID: 16537186
    [Abstract] [Full Text] [Related]

  • 39. Novel chemoradiotherapy with concomitant boost thoracic radiation and concurrent cisplatin and vinorelbine for stage IIIA and IIIB non-small-cell lung cancer.
    Imamura F, Konishi K, Uchida J, Nishino K, Okuyama T, Kumagai T, Kawaguchi Y, Nishiyama K.
    Clin Lung Cancer; 2014 Jul 01; 15(4):281-6. PubMed ID: 24656641
    [Abstract] [Full Text] [Related]

  • 40. Phase I results of vinorelbine with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small-cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI).
    Harada H, Seto T, Igawa S, Tsuya A, Wada M, Kaira K, Naito T, Hayakawa K, Nishimura T, Masuda N, Yamamoto N.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1777-82. PubMed ID: 21621337
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.